After USPSTF Recommendation, Prostate Cancer Screening Decline in Men Aged 50, Older

Share this content:
Screening for prostate cancer has declined significantly among men older than 50 years of age after the USPSTF guideline.
Screening for prostate cancer has declined significantly among men older than 50 years of age after the USPSTF guideline.

Screening for prostate cancer has declined significantly among men older than 50 years of age after the USPSTF guideline that discouraged PSA-based screening issued in 2012, according to a recent study published online ahead of print in the Journal of Clinical Oncology.

Michael Drazer, BS, and fellow researchers of the University of Chicago Medical Center conducted a trend analysis in order to determine the population-based impact of the 2012 recommendation.

“Previous USPSTF recommendations did not appreciably alter prostate cancer screening,” the authors noted.

Looking through the National Health Interview Survey to estimate the proportion of men 40 years and older who were screened for prostate cancer in 2013, they used an externally validated nine-year mortality index to analyze screening rates.

RELATED: Androgen Receptor Splice Variant 7 May Serve as Treatment Biomarker in Prostate Cancer

They found that while PSA-based screening did not significantly change from 2010 to 2013 for men 40-49 years of age, they significantly declined in men aged 50 to 59 years, 60 to 74 years, and 75 years or older.

In addition, a large percentage of men were screened despite high-risk of nine-year mortality, including about one third of men older than 75 years of age.

About 1.4 million men aged 65 years or older with high-risk of nine-year mortality were screened in 2013.

Reference

  1. Drazer, Michael W., et al. “National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.” Journal of Clinical Oncology. doi: 10.1200/JCO.2015.61.6532. [epub ahead of print]. June 8, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs